Respiratory dyskinesia and dysarthria from prolonged neuroleptic use: tardive dyskinesia?
D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects*; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D004401:Dysarthria / Q000139:chemically induced*; D004409:Dyskinesia, Drug-Induced / Q000209:etiology*; D006220:Haloperidol / Q000009:adverse effects; D006801:Humans; D008297:Male; D012120:Respiration Disorders / Q000139:chemically induced*; D013064:Speech Disorders / Q000139:chemically induced*; D013375:Substance Withdrawal Syndrome / Q000209:etiology; D013881:Thioridazine / Q000009:adverse effects
D014150:Antipsychotic Agents; D006220:Haloperidol; D013881:Thioridazine